Expert consensus on MRI diagnosis of liver fibrosis in chronic hepatitis B (version 2023) / 中华肝脏病杂志
Chinese Journal of Hepatology
; (12): 1009-1017, 2023.
Article
em Zh
| WPRIM
| ID: wpr-1009412
Biblioteca responsável:
WPRO
ABSTRACT
Chronic hepatitis B is a common chronic inflammatory disease of the liver in China that frequently results in sustained damage to the liver parenchyma, followed by liver fibrosis, and ultimately progresses to unfavorable outcomes such as cirrhosis, liver failure, and liver cancer. Liver fibrosis reversal can be achieved through early and effective intervention. Therefore, timely and accurate assessment of the degree of liver fibrosis is of great clinical significance for the treatment and prognosis assessment of patients with chronic hepatitis B. MRI plays a crucial role in the early assessment and monitoring of the therapeutic efficacy of liver fibrosis in chronic hepatitis B. Currently, there is a lack of uniform consensus on MRI scanning protocols and related diagnostic thresholds for liver fibrosis in chronic hepatitis B, which is not conducive to practical clinical evaluation and application. This expert consensus is based on a full review of relevant domestic and international literature and the formulation of methodologies based on evidence-based medical guidelines and standards to develop recommendations for MRI scanning techniques and the diagnosis of liver fibrosis in chronic hepatitis B, with a view to providing a clear basis for the clinical diagnosis.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Imageamento por Ressonância Magnética
/
Hepatite B Crônica
/
Consenso
/
Fígado
/
Cirrose Hepática
Limite:
Humans
Idioma:
Zh
Revista:
Chinese Journal of Hepatology
Ano de publicação:
2023
Tipo de documento:
Article